MDxHealth Q2 Revenue Up 16% to $27.2M; $20M Direct Placement at $0.454
MDXH sits 39% above its 52-week low of $0.4.
Summary
MDxHealth reported Q2 revenue growth of 16% to $27.2M, but net loss widened to $9.5M. The company also disclosed a $20M registered direct placement at $0.454/share, adding 44.05M shares.
Updates
· SEC 6-K — The offering closed on August 13, 2026, with net proceeds of approximately $20.0 million before expenses. The company amended its articles to reflect 95,417,382 shares outstanding.
Key Events · Earnings and Guidance · MDXH
-
Q2 Revenue Up 16%
Revenue of $27.2M, up 16% YoY, with sequential growth of $3.3M from Q1. Tissue-based test volume increased 13% sequentially.
-
Net Loss Widens 36%
Net loss of $9.5M vs $7.0M prior year, driven by higher operating expenses from the ExoDx acquisition. Adjusted EBITDA was $(2.3)M vs $1.1M prior year.
-
$20M Registered Direct Placement
44,052,862 shares sold at $0.454/share on August 11, 2026, for gross proceeds of $20M. Pro-forma cash as of June 30, 2026 would be $39.2M.
-
Resolve Business Discontinued
Resolve mdx wind-down completed; Delta Lab executed an Assignment for the Benefit of Creditors on August 3, 2026, including a $10.4M Novitas recoupment claim.
Analysis · MDXH · Industrial Applications And Services
MDxHealth reported Q2 revenue of $27.2 million, up 16% year-over-year, but net loss widened 36% to $9.5 million. The company also disclosed a $20 million registered direct placement priced at $0.454 per share, executed August 11, 2026. The placement is highly dilutive — 44.05 million new shares represent a substantial increase to the share count — and comes as the company faces Nasdaq delisting notices for failing the $1.00 bid price and $35 million market value requirements. The capital raise provides runway but underscores the company's distressed position.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 40.9% of the 1143 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.37%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDXH was trading at $0.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $23.7M. The 52-week trading range was $0.40 to $5.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.